Roche Holding AG – Company Snapshot & SWOT Analysis Market Report; Launched via MarketResearchReports.com

As per NAVADHI Market Research, the global pharmaceutical industry will we worth USD 1.57 trillion by 2023.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is one of the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.

Roche is also the in the forefront in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders.

Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry nine years in a row by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2018 employed about 94,442 people worldwide.

Roche Holding AG reported revenue of CHF 59.497 billion for the FY 2018 which saw an increase of 6.73% compared to FY 2017. This revenue is expected to increase by 5% and reach CHF 62.472 billion by FY 2019. Roche Holding AG registered highest revenue from United States market at including royalties which accounted for 47.20% of its total sales in FY 2018.

In total three US national wholesale distributors represent approximately a third of the Roche’s revenues in FY 2018. The three US national wholesale distributors are McKesson Corp. with CHF 9 billion (2017: CHF 7 billion), AmerisourceBergen Corp. with CHF 7 billion (2017: CHF 6 billion) and Cardinal Health, Inc. with CHF 5 billion (2017: CHF 5 billion). Approximately 95% of these revenues were in the Pharmaceuticals operating segment, with the residual in the Diagnostics segment.

Spanning over 31 pages and 10 exhibits, “Roche Holding AG – Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.

Scope of the Roche Holding AG – Company Snapshot & SWOT Analysis Report

– This report provides detailed information about Roche Holding AG including value chain analysis, financial performance, business strategy and SWOT analysis.

– The report identifies the growth drivers and inhibitors for global pharmaceutical market.

– This report provides information about current and future trends for global pharmaceutical market.

For more details visit: https://www.marketresearchreports.com/navadhi/roche-holding-ag-company-snapshot-swot-analysis

Browse more on   Pharma andHealthcare Market Research Reports

 

Read our Interactive Market Research Blog

 

About MarketResearchReports.com

MarketResearchReports.com is world’s largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

About NAVADHI Market Research Pvt Ltd.

NAVADHI is a market research company that helps global firms differentiate themselves, break market entry barriers, track their investments, develop business strategies and plan for future by providing actionable market research intelligence that helps them succeed.

Press Contact:

Mr. Sudeep Chakravarty

Director – Operations

MarketResearchReports.com

USA: +1-302-703-9904

Contact us for your market research requirements: https://www.marketresearchreports.com/contact